Product Information
CARDURA XL 4 MG TABLET is a brand product labeled by Viatris Specialty LLC, priced at $6.9966 per EA under NDC 58151007893. Its NADAC has been published 115 times since Jun 12, 2024.
FDA first approved this application on Feb 22, 2005.
The High Outlier badge above means this manufacturer's average price in the doxazosin mesylate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
4 mg/1
Manufacturer
Viatris Specialty LLCNDC
58151007893
Classification
Brand
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DOXAZOSIN MESYLATEApproval Type
New Drug (NDA)
FDA Application
NDA021269FDA Approved
2/22/2005
On Market Since
4/23/2024
Pharmacological Classes
Price Statistics
The NADAC for CARDURA XL 4 MG TABLET has been published 115 times since Jun 12, 2024, and over the history we have for it it has risen 4.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.9966 per EA |
|---|---|
| All-time high | $6.9966 (Aug 19, 2026) |
| All-time low | $6.6415 (Sep 17, 2025) |
| 52-week high | $6.9966 |
| 52-week low | $6.6415 |
| Median price | $6.6696 |
| Average price | $6.7539 |
| Largest weekly change | +5.0% (Jan 7, 2026) |
| Weeks tracked | 115 |
| Tracking since | Jun 12, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CARDURA XL 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CARDURA XL 4 MG TABLET, manufactured by Viatris Specialty LLC, is $6.9966 per EA (NDC 58151007893), effective Aug 19, 2026.
How has the price of CARDURA XL 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for CARDURA XL 4 MG TABLET has risen 4.9%. It has been tracked across 115 weekly CMS publications since Jun 12, 2024.
What are the highest and lowest recorded NADAC prices for CARDURA XL 4 MG TABLET?
Since Jun 12, 2024, the NADAC for CARDURA XL 4 MG TABLET has ranged from a low of $6.6415 (Sep 17, 2025) to a high of $6.9966 (Aug 19, 2026), with a median of $6.6696 per EA.
Are there cheaper alternatives to CARDURA XL 4 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DOXAZOSIN MESYLATE 4 MG TAB, is $0.0857 per EA — about 99% below CARDURA XL 4 MG TABLET.
Who manufactures CARDURA XL 4 MG TABLET?
CARDURA XL 4 MG TABLET (NDC 58151007893) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.